Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hoffman

Showing results (821-830 of 933) with videos related to

Pageof 94
Sort By:
Journal of Medicinal Chemistry|March 7, 2018
Discovery of [ cis-3-({(5 R)-5-[(7-Fluoro-1,1-dimethyl-2,3-dihydro-1 H-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridin-6(5 H)-yl}carbonyl)cyclobutyl]acetic Acid (TAK-828F) as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse AgonistMitsunori Kono, Atsuko Ochida, Tsuneo Oda, et al.
Journal of Geodesy|January 11, 2020
Modernizing and Expanding the NASA Space Geodesy Network to Meet Future Geodetic RequirementsS M Merkowitz, S Bolotin, P Elosegui, et al.
ACS Medicinal Chemistry Letters|October 18, 2019
Identification of Novel, Potent, and Orally Available GCN2 Inhibitors with Type I Half Binding ModeJun Fujimoto, Osamu Kurasawa, Terufumi Takagi, et al.
Nature Communications|September 5, 2020
Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohortsSara R Rashkin, Rebecca E Graff, Linda Kachuri, et al.
Physical Review Letters|September 10, 2025
Demonstration of a Novel Radiochemical Mix Diagnostic for Fusion Implosions at the National Ignition FacilityS A MacLaren, E L Dewald, D A Martinez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid TumorsCorey C Foster, Gini F Fleming, Theodore G Karrison, et al.
Nature Communications|February 13, 2021
Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohortsRebecca E Graff, Taylor B Cavazos, Khanh K Thai, et al.
Public Health|June 7, 2024
Features and frequency of use of electronic health records in primary care across 20 countries: a cross-sectional studyG Kerr, N Kulshreshtha, G Greenfield, et al.
Human Mutation|June 5, 2010
Type I hyperprolinemia: genotype/phenotype correlationsAudrey Guilmatre, Solenn Legallic, Gary Steel, et al.
JMIR Research Protocols|July 22, 2021
Evaluating the Impact of COVID-19 on the Adoption of Virtual Care in General Practice in 20 Countries (inSIGHT): Protocol and Rationale StudyAna Luísa Neves, Edmond Li, Alice Serafini, et al.
Pageof 94

Showing results (821-830 of 933) with videos related to

Sort By:
Pageof 94
Journal of Medicinal Chemistry|March 7, 2018
Discovery of [ cis-3-({(5 R)-5-[(7-Fluoro-1,1-dimethyl-2,3-dihydro-1 H-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridin-6(5 H)-yl}carbonyl)cyclobutyl]acetic Acid (TAK-828F) as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse AgonistMitsunori Kono, Atsuko Ochida, Tsuneo Oda, et al.
Journal of Geodesy|January 11, 2020
Modernizing and Expanding the NASA Space Geodesy Network to Meet Future Geodetic RequirementsS M Merkowitz, S Bolotin, P Elosegui, et al.
ACS Medicinal Chemistry Letters|October 18, 2019
Identification of Novel, Potent, and Orally Available GCN2 Inhibitors with Type I Half Binding ModeJun Fujimoto, Osamu Kurasawa, Terufumi Takagi, et al.
Nature Communications|September 5, 2020
Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohortsSara R Rashkin, Rebecca E Graff, Linda Kachuri, et al.
Physical Review Letters|September 10, 2025
Demonstration of a Novel Radiochemical Mix Diagnostic for Fusion Implosions at the National Ignition FacilityS A MacLaren, E L Dewald, D A Martinez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid TumorsCorey C Foster, Gini F Fleming, Theodore G Karrison, et al.
Nature Communications|February 13, 2021
Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohortsRebecca E Graff, Taylor B Cavazos, Khanh K Thai, et al.
Public Health|June 7, 2024
Features and frequency of use of electronic health records in primary care across 20 countries: a cross-sectional studyG Kerr, N Kulshreshtha, G Greenfield, et al.
Human Mutation|June 5, 2010
Type I hyperprolinemia: genotype/phenotype correlationsAudrey Guilmatre, Solenn Legallic, Gary Steel, et al.
JMIR Research Protocols|July 22, 2021
Evaluating the Impact of COVID-19 on the Adoption of Virtual Care in General Practice in 20 Countries (inSIGHT): Protocol and Rationale StudyAna Luísa Neves, Edmond Li, Alice Serafini, et al.
Pageof 94